MU
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study | Cancer Medicine | 2017 | 732 | 297 | |||
Breast cancer family history leads to early breast cancer detection and optimal management | Cancer Causes and Control | 2017 | 569 | 5 | |||
Right colon cancer: Left behind | European journal of surgical oncology | 2016 | 513 | 383 | |||
The incidence of colon cancer among patients diagnosed with left colonic or sigmoid acute diverticulitis is higher than in the general population | Surgical endoscopy | 2015 | 732 | 0 | |||
Abstract P3-07-09: Trends and determinants of breast cancer survival among unscreened women: A population-based study | Cancer Research | 2015 | 406 | 0 | |||
Le Cancer à Genève: Incidence, mortalité, survie et prévalence 2007-2010 | 2015 | 512 | 93 | ||||
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) | Lancet | 2015 | 724 | 411 | |||
Abstract P3-07-08: Don't mix apples and oranges: Not all non-screen-detected breast cancers belong to the same category in a cancer registry dataset | Cancer Research | 2015 | 485 | 0 | |||
Stage IVB endometrial cancer: clinical course and survival of patients with single and multiple metastases | European journal of gynaecological oncology | 2015 | 467 | 0 | |||
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study | Lancet oncology | 2014 | 578 | 0 | |||
Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients | British journal of cancer | 2014 | 681 | 1 | |||
Corrigendum to “Trends in incidence of breast cancer among women under 40 in seven European countries: A GRELL cooperative study” [Cancer Epidemiol. 37 (2013) 544–549] | Cancer epidemiology | 2014 | 451 | 450 | |||
Planning for the future: cancer incidence projections in Switzerland up to 2019 | BMC public health | 2014 | 690 | 288 | |||
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study | Lancet oncology | 2014 | 606 | 3 | |||
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study | Lancet oncology | 2014 | 670 | 1 | |||
Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study | BMC urology | 2014 | 742 | 304 | |||
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study | Haematologica | 2013 | 646 | 726 | |||
Cancer prevalence estimates in Europe at the beginning of 2000 | Annals of oncology | 2013 | 693 | 368 | |||
Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study | Cancer epidemiology | 2013 | 510 | 0 | |||
Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990 | European journal of cancer | 2013 | 542 | 0 | |||
Right colon cancer : left behind ? | British journal of surgery | 2013 | 441 | 341 | |||
Testicular cancer in Europe and the USA: survival still rising among older patients | Annals of oncology | 2013 | 769 | 366 | |||
How many ovarian cancer patients are eligible for fertility-sparing surgery? | European journal of obstetrics, gynecology, and reproductive biology | 2013 | 594 | 3 | |||
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project | Cancer epidemiology | 2013 | 583 | 1 | |||
Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002 | Haematologica | 2013 | 1 209 | 624 | |||
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths | Annals of oncology | 2012 | 1 158 | 336 | |||
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe | European journal of cancer | 2012 | 557 | 0 | |||
Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics | International journal of cancer | 2012 | 533 | 1 | |||
Embryonal cancers in Europe | European journal of cancer | 2012 | 542 | 0 | |||
Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III | European journal of cancer | 2012 | 569 | 1 | |||
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade | Acta oncologica | 2012 | 524 | 0 | |||
Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study | International journal of cancer | 2012 | 546 | 0 | |||
Incidence, survival and prevalence of myeloid malignancies in Europe | European journal of cancer | 2012 | 532 | 1 | |||
Rare thoracic cancers, including peritoneum mesothelioma | European journal of cancer | 2012 | 550 | 0 | |||
Carcinoma of endocrine organs: results of the RARECARE project | European journal of cancer | 2012 | 533 | 1 | |||
Epidemiology of glial and non-glial brain tumours in Europe | European journal of cancer | 2012 | 487 | 0 | |||
Oesophageal cancer survival in Europe: a EUROCARE-4 study | Cancer epidemiology | 2012 | 561 | 1 | |||
Survival of European patients with central nervous system tumors | International journal of cancer | 2012 | 522 | 0 | |||
Incidence and survival of rare urogenital cancers in Europe | European journal of cancer | 2012 | 494 | 1 | |||
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 | European journal of cancer | 2012 | 526 | 1 | |||
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe | European journal of cancer | 2012 | 468 | 0 | |||
Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma | The oncologist | 2012 | 627 | 520 | |||
Tumor incidence in related hematopoietic stem cell donors | Bone marrow transplantation | 2011 | 486 | 0 | |||
Rare cancers are not so rare: the rare cancer burden in Europe | European journal of cancer | 2011 | 637 | 1 | |||
Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project | Haematologica | 2011 | 531 | 0 | |||
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study | Annals of oncology | 2011 | 531 | 1 | |||
Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva | Breast cancer research and treatment | 2010 | 651 | 225 | |||
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors | Annals of oncology | 2010 | 539 | 1 | |||
Impact of obesity on diagnosis and treatment of breast cancer | Breast cancer research and treatment | 2010 | 562 | 310 | |||
Le Cancer à Genève: Incidence, mortalité, survie, prévalence 2003-2006 | 2009 | 364 | 55 | ||||
Lymph node ratio as an alternative to pN staging in node-positive breast cancer | Journal of clinical oncology | 2009 | 623 | 3 | |||
Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment? | Gynecologic oncology | 2009 | 653 | 1 | |||
Increased risk of second cancer among patients with ovarian borderline tumors | Gynecologic oncology | 2008 | 551 | 0 | |||
Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas | European journal of gynaecological oncology | 2008 | 526 | 0 | |||
Cancers de la thyroïde : expérience genevoise | Annales de chirurgie | 2001 | 552 | 1 | |||
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma | Journal of thoracic and cardiovascular surgery | 2000 | 496 | 0 |